Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealing

1 Feb 2018 09:39

RNS Number : 6200D
Ergomed plc
01 February 2018
 

Ergomed Plc

("Ergomed" or the "Company")

 

Directors' Dealing

 

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 1 February 2018, Mr Peter George, Chairman of the Company, bought 500,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share from Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company. Separately, in response to excess demand from the placing announced by the Company this morning, Dr Miroslav Reljanovic sold an additional 2,000,000 Shares at a price of 190p.

 

Following these transactions, Mr Peter George holds 776,250 shares (representing 1.8 per cent. of the Company's issued share capital and 1.7 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning) and Dr Miroslav Reljanovic's holding has reduced to 15,132,237 shares (representing 35.5 per cent. of the Company's issued share capital and 33.8 per cent. of the Company's issued share capital following admission of the Placing Shares relating to the Placing announced by the Company earlier this morning).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1) Peter George

2) Dr Miroslav Reljanovic

2

Reason for the notification

a)

Position/status

1) Chairman

2) Founder and Executive Vice-Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

1) Purchase of shares

2) Sale of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

190p

500,000

190p

2,500,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

1) 500,000

2) 2,500,000

 

1) 190p

2) 190p

 

1) £950,000.00

2) £4,750,000.00

f)

Date of the transaction

1 February 2018

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Joint Broker)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEANAFEDSPEEF
Date   Source Headline
16th Nov 20167:00 amRNSResearch Update from Modus Therapeutics
15th Nov 20164:33 pmRNSHolding(s) in Company
1st Nov 20167:00 amRNSCo-Development Agreement with Asarina AB
24th Oct 20167:00 amRNSErgomed notes news from co-development partner
14th Oct 20167:00 amRNSFourth licensing agreement for Zoptrex
26th Sep 20167:00 amRNSHalf-year Report
22nd Sep 20167:00 amRNSContract win validates rationale of acquisitions
16th Sep 201610:56 amRNSErgomed receives a "buy" recommendation
8th Sep 20167:00 amRNSRecruitment completed in phase IIa clinical trial
7th Sep 201611:30 amRNSNotice of Results
2nd Sep 20167:00 amRNSCo-development partner announces licensing deals
15th Aug 20167:01 amRNSChange of Nominated Adviser
15th Aug 20167:00 amRNSDisclosure of Directors' Appointments
27th Jun 20161:55 pmRNSResult of AGM
27th Jun 20167:00 amRNSUS expansion and opening of office in Boston
20th Jun 20165:49 pmRNSNotice of AGM
14th Jun 201611:49 amRNSHolding(s) in Company
13th Jun 20167:00 amRNSAcquisition
6th Jun 20163:31 pmRNSHolding(s) in Company
31st May 20164:45 pmRNSTotal Voting Rights
25th May 201611:55 amRNSHolding(s) in Company
23rd May 201611:10 amRNSResult of Meeting
16th May 20167:00 amRNSPlacing Update
4th May 201612:30 pmRNSProposed acquisition of Haemostatix Limited
30th Mar 201612:00 pmRNSNotice of Results
1st Feb 20161:42 pmRNSHolding(s) in Company
1st Feb 20167:00 amRNSTrading Statement
11th Jan 20167:02 amRNSErgomed Award of Share Options to Director
11th Jan 20167:00 amRNSErgomed announces Board changes
24th Dec 20157:00 amRNSErgomed Awards Share Options
17th Dec 20157:00 amRNSHolding(s) in Company
16th Dec 20157:00 amRNSErgomed Update on Co-Development Partnerships
5th Nov 20157:00 amRNSHolding(s) in Company
29th Oct 201510:00 amRNSErgomed plc to present at German Equity Forum 2015
21st Oct 20159:21 amRNSErgomed Co-Development Partner News
14th Oct 20157:00 amRNSErgomed's Co-Development Partner News
13th Oct 20157:00 amRNSErgomed and Dilaforette Initiate Phase II
5th Oct 20151:09 pmRNSErgomed expands co-development with CEL-SCI
29th Sep 20157:01 amRNSErgomed Interim Results 2015
23rd Sep 20158:00 amRNSErgomed shortlisted for Leading Industry Award
15th Sep 20157:00 amRNSNotice of Results
14th Aug 20157:00 amRNSCo-development partner news
21st Jul 20152:30 pmRNSHolding(s) in Company
20th Jul 20154:20 pmRNSSecondary Placing Of Ordinary Shares in Ergomed
14th Jul 20159:56 amRNSCo-development partner news
10th Jul 20157:00 amRNSAppointment of Director - additional information
2nd Jul 20157:00 amRNSErgomed Strengthens Management Team & Board
30th Jun 201512:43 pmRNSCo-development partner news
25th Jun 20151:06 pmRNSCo-development partner news
19th Jun 201512:35 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.